Earnings Feed
Start Free
NEVRO CORP·4

Jul 5, 8:33 PM ET

DEMANE MICHAEL F 4

4 · NEVRO CORP · Filed Jul 5, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-06-30+598→ 44,900 total
Holdings

  • Common Stock

    (indirect: See footnote)
    49,911

  • Common Stock

    (indirect: See footnote)
    47,980

  • Common Stock

    (indirect: See footnote)
    11,600

  • Common Stock

    (indirect: See footnote)
    148,775

  • Common Stock

    (indirect: See footnote)
    71,986
Footnotes (7)
  • [F1]Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
  • [F2]Includes 4,155 restricted stock units.
  • [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
  • [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
  • [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
  • [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.
  • [F7]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4